Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3727_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
104 Chapter 10 Evaluation of hypercoagulable states and molecular markers of acute venous thrombosis
https://t.me/med1917
ill patients with COVID-19. N Engl J Med, 2021. 385(9): p.790–802.
84. Lopes, R.D., etal., Therapeutic versus
prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): An open-label, multicentre, randomised, controlled trial. Lancet,
2021. 397(10291): p.2253–63.
85. Spyropoulos, A.C., etal., Efcacy and
safety of therapeutic-dose heparin vs standard prophylactic or interme­diate-dose heparins for thromboprophy­laxis in high-risk hospitalized patients with COVID-19: The HEP-COVID randomized clinical trial. JAMA Intern
Med, 2021. 181(12): p.1612.
86. Pilia, E., etal., Efcacy and safety of
heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: Ameta-analysis of multicenter randomized controlled trials. J Thromb
Thrombolysis, 2022. 54(3): p.420–30.
87. Urano, T., etal., COVID-19 and thrombosis: Clinical aspects. Curr Drug Targets, 2022. 23(17): p.1567–72.
88. Paz Rios, L.H., etal., Prognostic value of
venous thromboembolism risk assessment models in patients with severe COVID-
19. TH Open, 2021. 5(2): p. e211–9.
89. Ramacciotti, E., etal., Rivaroxaban ver­sus no anticoagulation for post-discharge
thromboprophylaxis after hospitali­sation for COVID-19 (MICHELLE): An open-label, multicentre, rando­mised, controlled trial. Lancet, 2022.
399(10319): p.50–9.
90. Olson, J.D., Laboratory diagnosis of
thrombophilia: Why, who, what, when, how to test. Lab Hematol, 2004. 10(3):
p.172.
91. Golemi, I., etal., Venous thromboembo- lism prophylaxis using the Caprini score. Dis Mon, 2019. 65(8): p.249–98.
92. Gould, M.K., etal., Prevention of VTE
in nonorthopedic surgical patients: Anti­thrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest, 2012. 141(2
Suppl): p. e227S–77S.
93. Wilson, S., etal., Thrombosis prophylaxis
in surgical patients using the Caprini Risk Score. Curr Probl Surg, 2022.
59(11): p.101221.
94. Lobastov K, Urbanek T, Stepanov E, Lal
BK, Marangoni J, Krauss ES, Cronin M, Dengler N, Segal A, Welch HJ, Gianesini S, Chen X, Caprini JA. The Thresholds of Caprini Score Associated With Increased Risk of Venous Thromboem­bolism Across Different Specialties: A Systematic Review. Ann Surg. 2023 Jun 1;277(6):929–937.
95. Kakkar, V.V., etal., Prevention of Fatal
Postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Lancet, 1977. 1(8011):
p. 567–9.
96. Collins, R., etal., Reduction in fatal
pulmonary embolism and venous throm­bosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl
J Med, 1988. 318(18): p.1162–73.
97. Haas, S., etal., Prevention of fatal pul-
monary embolism and mortality in surgi­cal patients: Arandomized double-blind comparison of LMWH with unfractio­nated heparin. Thromb Haemost, 2005.
94(4): p.814–9.
98. Catterick, D., and B.J. Hunt, Impact of
the national venous thromboembolism risk assessment tool in secondary care in England: Retrospective population-based database study. Blood Coagul Fibrinoly-
sis, 2014. 25(6): p.571–6.
99. Cassidy, M.R., Rosenkranz, P., and McA­neny, D., Reducing postoperative venous
thromboembolism complications with a standardized risk-stratied prophylaxis protocol and mobilization program.
J Am Coll Surg, 2014. 218(6): p.1095–104.
CHAPTER
11
https://t.me/med1917
Duplex ultrasound scanning
for acute venous disease
Rhusheet Patel and Timothy K. Liem
11.1 INTRODUCTION
The incidence of rst-time extremity venous thromboem­bolism (VTE) has been estimated to range between 70 and 113 per 100,000 population/year, with at least 350,000 cases of deep vein thrombosis (DVT) and pulmonary embolism (PE) occurring each year in the United States. is a frequent complication in patients who undergo major surgery and prolonged hospitalization, and the Surgeon General’s 2008 Call to Action described VTE as the most common cause of preventable in-hospital mortality.
Successful therapy requires prompt diagnosis and ini­tiation of antithrombotic therapy within the rst 24hours after onset of symptoms. Prior to the 1980s, patients were more commonly diagnosed with impedance plethysmogra­phy (IPG), I trast venography. However, the accuracy of IPG is limited, demonstrating decreased sensitivity in patients with nonoc­clusive proximal thrombosis, those with duplicate femoral or popliteal veins when only one channel is affected, and those with isolated calf DVT. Labeled brinogen scanning and contrast venography are invasive, more labor intensive, time consuming, and not readily available at every medical facility. The use of B-mode and Doppler for the assessment of venous disease was rst introduced in 1968, but did not become a validated diagnostic tool for another decade. Since the 1980s, the venous duplex examination has been the mainstay for the diagnosis of acute DVT and supercial venous thrombosis (SVT). Although venous duplex imag­ing initially was utilized to detect thrombosis in the upper and lower extremity venous beds, duplex now is being uti­lized for the detection of thrombosis in the iliocaval and mesenteric veins as well. This chapter will discuss indica­tions for testing, examination techniques, accuracy of the venous duplex examination in various anatomic beds, and controversies in the imaging of acute venous disease.
121
-labeled brinogen nuclear scanning, and con-
1,2
It
3
4–6
11.2 INDICATIONS FOR TESTING
Venous duplex ultrasound has become the imaging test of rst choice to aid in the diagnosis of venous thrombosis. This is related to multiple factors, which include its rela­tively high accuracy in detecting upper and lower extremity
DVT and very low risk for complications. Duplex imag­ing also has become widely adopted due to the capacity for portable bedside examinations and the greater avail­ability of vascular laboratories and ultrasound services at more health care facilities. In fact, this mode of imaging is so widely available, it may have become a victim of its own success, with multiple reports suggesting that health care providers generally have a low threshold for ordering duplex scans in order to “rule out” DVT. to an overutilization of venous ultrasound, with ultrasound testing demonstrating the absence of DVT in as many as 80%–90% of patients.
More recent criteria have been published to standardize the appropriate use of duplex scanning for acute venous disease. from numerous professional societies and categorizes var­ious clinical indications as either appropriate or rarely appropriate, based on the anatomic region in question. Extremity pain and edema are common and appropri­ate indications for duplex imaging of the upper or lower extremity veins. Additional indications include follow-up surveillance for patients with isolated calf DVT who are unable to receive therapeutic anticoagulation and patients with isolated supercial vein thrombosis when near a junc­tion with the deep venous system. Although duplex sur­veillance after endothermal ablation is a listed and widely practiced indication (Figure11.1), the utility and cost-ef­fectiveness of routine venous imaging after radiofrequency or laser ablation remain debated in the literature.
duplex testing, the majority of patients will test negative for deep or supercial vein thrombosis. In patients with clinical suspicion for lower extremity DVT, clinical deci­sion rules, in combination with qualitative or quantitative D-dimer assays, have been evaluated as a means to “rule out” DVT without having to perform further diagnostic testing. ical decision scoring system and is shown in Table 11.2. Earlier descriptions of the Wells rule dichotomized patients into likely versus unlikely for DVT. An unlikely Wells rule score (<1), combined with a negative D-dimer assay, is associated with a very low probability of DVT (<2%), except in patients with active malignancy and those with recurrent VTE. undergo further testing with venous duplex imaging. Use
9
Table 11.1 summarizes the recommendations
Despite the use of standardized indications for venous
8,11,12
The Wells rule is the most widely studied clin-
12
Patients with a Wells score >1 should
7,8
This contributes
10
DOI: 10.1201/9781003328971-13
105105
106 Chapter 11 Duplex ultrasound scanning for acute venous disease
https://t.me/med1917
TABLE 11.1 Guidelines regarding the appropriate use of venous duplex scanning for patients with venous disease,
categorized according to anatomic region
Anatomic region Appropriate Rarely appropriate
Upper extremity • Limb edema
• Nonarticular upper extremity pain or palpable cord
• New pain or edema in presence of known UEDVT
Lower extremity • Limb edema
• Nonarticular lower extremity pain or palpable cord
• Pulmonary embolism
• New pain or edema in presence of known LEDVT
• Surveillance of calf DVT for proximal extension when anticoagula­tion contraindicated
• Surveillance for GSV or SSV SVT when near a deep vein junction
• Early follow-up after endovenous saphenous ablation
• Patent foramen ovale with suspected paradoxical embolism
• Evidence of LE venous obstruction on plethysmography suggest­ing DVT
Inferior vena cava and iliac veins
Hepatoportal and renal veins
• Routinely or selectively in conjunction with lower extremity scan­ning if proximal DVT was identied or if abnormal ow pattern in one or both common femoral veins
• May be appropriate for procedure planning prior to IVC lter place­ment
• Evaluation of cirrhosis without ascites/hepatomegaly/splenomegaly/ portal hypertension
• Evaluation of abnormal LFTs and jaundice if no alternative diagnosis
• Surveillance after TIPS
• Fever of unknown origin in absence of indwelling venous catheter
• SOB in patient with known UEDVT
• Screening asymptomatic patients with prolonged ICU stay, prior to pacemaker/ debrillator, for monitoring of a functional venous catheter, patients with hypercoag­ulable state, or positive D-dimer testing
• Screening asymptomatic patients with prolonged ICU stay, after orthopedic surgery, with hypercoagulable state, or positive D-dimer testing
• Stand-alone testing without LE venous scanning
• Abdominal pain
• Abdominal bruit
• Fever of unknown origin
• Initial diagnostic test for jaundice
Abbreviations: UEDVT=upper extremity deep vein thrombosis, LEDVT=lower extremity DVT, SOB=shortness of breath, GSV=great saphenous vein, SSV=small saphenous vein, SVT=superficial vein thrombosis, LFT=liver function test, TIPS=transjugular intrahepatic portosystemic shunt.
Source: Adapted from Heather Gornik, etal. “ACCF/ACR/AIUM/ASE/IAC/SCAI/SCVS/SIR/SVM/SVS/SVU 2013 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part II: Testing for Venous Disease and Evaluation of Hemodialysis Access,” Journal of the American College of Cardiology 62 (2013): 649–665.
of such a clinical decision algorithm potentially can elimi­nate the need for venous duplex imaging in about one-third of patients.
10
The American College of Chest Physicians (ACCP) Evidence-Based Clinical Practice Guidelines sug­gest the use of a clinical assessment tool in combination with D-dimer assays and venous duplex scanning (Grade 2B recommendation). However, the algorithms suggested by the ACCP guidelines trichotomize the Wells rule into
requiring intervention. Doppler imaging is used to identify portal vein thrombo­sis in patients with appropriate clinical exam and history, including cirrhosis, hepatocellular carcinoma, intrabdomi­nal sepsis, acute pancreatitis, hematologic malignancy, or other known hypercoagulability. If portal thrombosis is identied, further imaging with CT or MRI is warranted to identify the extent of the clot and associated pathology.
16
Beyond liver transplantation,
low (<0), moderate (1–2), and high probability (>3). The suggested diagnostic algorithms are signicantly more complicated, potentially decreasing their utility and appeal for many health care providers.
13
Similar clinical decision rules also have been described for patients who are sus­pected of upper extremity DVT, but further conrmation is warranted before they can be applied.
14
Acute indications for ultrasound imaging of the portal and renal vein are largely limited to liver transplantation. While no consensus recommendations for the frequency and timing of post-transplantation imaging exist, portal venous duplex, as part of a complete liver ultrasound, is the imaging modality of choice in cases of suspected early vascular complication.
15
Routine duplex imaging in the immediate postoperative period has also been shown to be effective in early identication of vascular complications
11.3 EXAMINATION TECHNIQUE
11.3.1 Lower extremity venous exam
The patient is placed supine and comfortable, with the bed in a slight reversed Trendelenburg position. Optimally, the room is warmed, but this is not always possible when portable venous examinations are performed in the emer­gency department, hospital ward, or intensive care unit. Examination for lower extremity venous thrombosis usu­ally is performed with slight external rotation of the hip and exion of the knee, the latter of which allows access to the popliteal vein from the posterior approach. Alin­ear transducer with a broadband frequency in the range of
11.1 Grayscale images of patients who developed endothermal
https://t.me/med1917
heat-induced thrombosis (EHIT) after endovenous ablation of the great saphenous vein (a) and small saphenous vein (b).
TABLE 11.2 Clinical model for predicting pretest proba-
bility of deep vein thrombosis (DVT)
Clinical characteristic Score
Active cancer (<6 months) Paralysis, paresis, or recent plaster immobilization
of leg
Recently bedridden >3 days or major surgery <4
weeks Localized tenderness along deep venous system Entire leg swollen Calf swelling >3cm than asymptomatic side (10cm
below tibial tuberosity) Pitting edema conned to symptomatic leg Collateral supercial veins Previous documented DVT Alternative diagnosis at least as likely as DVT
Source: Adapted from Geersing, G.J., etal. “Exclusion of Deep Vein Throm­bosis Using the Wells Rule in Clinically Important Subgroups: Individual Data Meta-Analysis.” British Medical Journal 348 (2014): g1340
DVT unlikely if score < 1 and likely if > 1.
1 1 1 1 1 1 1 1 1
–2
5–10 MHz usually is employed for assessment of the lower extremity and upper extremity veins. Some anatomic loca­tions require the use of lower frequencies within this range, especially in patients with large body habitus.
11.3 Examination technique 107
Exam standardization is of paramount importance, not only to improve diagnostic accuracy but also to allow comparison with prior imaging studies, whether or not performed at the same institution. Standards and guide­lines for duplex assessment of acute venous disease may be found with the Intersocietal Accreditation Commission (IAC) for vascular testing.
17
Venous segments are examined for thrombosis or patency using the following criteria: (1) venous compressibility (or coaptation); (2) spectral Dop­pler waveform assessments of spontaneous venous ow, phasic ow, or ow with distal augmentation; and (3) thrombus visualization. Not all of these criteria are appli­cable to all venous segments.
Compressibility of the vein should be assessed with transverse grayscale imaging at the saphenofemoral junc­tion, as well as the common femoral, femoral (proximal, mid, and distal), popliteal, posterior tibial, and peroneal veins (Figure 11.2). The IAC standards and guidelines include Doppler waveform assessment of the common femoral and popliteal veins at a minimum. Our institu­tional protocol adds an evaluation of the great saphenous veins for compressibility and Doppler assessment of deep femoral, femoral, posterior tibial, and peroneal veins for evaluation of phasic ow or ow in response to distal aug­mentation (Figure 11.3). The supercial veins (varicose veins, small saphenous) and muscular veins of the calf (gas­trocnemial and soleal) also should be imaged if the patient’s symptoms warrant further examination. The anterior tibial veins are excluded from most routine venous duplex stud­ies due to their small size and relatively low likelihood of anterior tibial DVT (1%).
18
Thrombus visualization is accomplished with both B-mode and color ow imaging, allowing for direct visu­alization of occlusive and nonocclusive thrombus as well (Figure11.4). B-mode imaging is useful when evaluating the degree of echogenicity within a visualized thrombus, the thickness of a vein wall, and the size of the vein (con­tracted versus dilated). Aneurysmal or ectatic segments of the deep and supercial system should also be noted. Hyperechoic thrombus, a thickened vein wall, and a con­tracted vein suggest a more chronic process. Doppler and color ow assessment typically are performed with the probe oriented longitudinally, with color sensitivity set for low ow, and proper Doppler angulation.
11.3.2 Iliac vein and inferior vena cava
exam
Any suggestion of DVT extending above the inguinal lig­ament should warrant evaluation of the iliac veins and inferior vena cava (IVC). This includes direct evidence, such as visible thrombus above the common femoral vein, or indirect evidence, such as continuous ow in the common femoral vein with lack of respiratory variation. Sonographic evaluation of these deeper structures usually requires lower-frequency abdominal probes, ranging from
2.0 to 5.0 MHz. Optimal visualization of the IVC and iliac veins may require positioning in the supine, semi-right lateral, or semi-left lateral decubitus positions, with the patient fasting for at least 6hours prior to the duplex scan. Iliac veins and the IVC are too deep to compress, and the imaging evaluation typically is limited to the Doppler ow
11
108 Chapter 11 Duplex ultrasound scanning for acute venous disease
https://t.me/med1917
11.2 Transverse grayscale image of the left common femoral vein (CFV) at the saphenofemoral junction without compression (a) and
with compression (b). Similar grayscale image of the left femoral vein (FV) without compression (c) and with compression (d). The white arrows indicate the location of the compressed vein.
evaluation in combination with color ow imaging. Body habitus may ultimately limit exam of the iliac veins, and if proximal thrombosis of the pelvic and abdominal veins is suspected, CT or catheter-based venography may be indi­cated in symptomatic patients.
11.3.3 Upper extremity venous exam
Duplex examination of the upper extremity veins is more challenging than that of the lower extremity veins. The mid-portion of the subclavian vein is partially obscured by the overlying clavicle, and the innominate vein is obscured at the thoracic inlet. The examination is started with the patient in the supine position, with the ipsilateral arm abducted and externally rotated to facilitate access to the axillary and brachial veins. The head is rotated away to allow imaging of the internal jugular vein. A5- to 10-MHz probe is utilized for the upper extremity veins, with curved probes reserved for larger patients, especially in the region of the axilla.
Assessment for upper extremity venous thrombosis and patency is similar to that of the lower extremity. The IAC standards include transverse grayscale imaging for compressibility of the internal jugular, subclavian, axillary,
brachial, basilic, and cephalic veins, with additional assess­ment of antecubital and forearm deep veins if symptoms suggest thrombosis. DVT, attention should be paid to distinguish a peri-catheter brin sheath from true vein wall thrombus. Fibrin deposi­tion upon the thrombogenic catheter surface is expected in almost all cases, while mural thrombus or thrombus at the catheter tip may warrant antithrombotic treatment. Spectral Doppler waveform assessments for spontaneous and phasic ow and/or ow with augmentation usually is performed with longitudinal views of the ipsilateral inter­nal jugular and axillary veins and bilateral subclavian veins (Figure11.3). In contrast to the lower extremities, upper extremity venous phasic ow is more pronounced during inspiration.
14
In the evaluation of catheter-related
19
11.3.4 Portomesenteric and hepatic venous exam
Ultrasound diagnosis of portomesenteric venous throm­bosis was rst reported in the late 1970s, and duplex assessment of the hepato-portal and mesenteric venous cir­culation remains an important tool in the evaluation and follow-up of patients with liver disease.
20
Portal and mes-
11.3 Examination technique 109
(b
https://t.me/med1917
(a)
P
(c)
P
11
)
P
(d)
11.3 Doppler waveform assessment of the common femoral vein (a) and femoral vein (b) in response to distal augmentation. Tib-
ial veins often are smaller and multiple, and assessment usually is made with B-mode imaging and color ow. Color ow at the posterior tibial vein (c) and at the conuence of the posterior tibial and peroneal veins (d). In image (d), the paired peroneal veins demonstrate an opposite color ow signal (red) than the paired posterior tibial veins (blue) due to the angle of the veins in relation to the transducer.
enteric venous imaging is one component of a more com­prehensive evaluation, which includes the intrahepatic and extrahepatic portal vein, superior mesenteric and splenic veins, hepatic veins, IVC, liver parenchyma, and any por­tosystemic shunts or collateral pathways.
17
Scanning of the portomesenteric veins often requires the use of a curved abdominal transducer with a lower fre­quency range of 2–5 MHz for better tissue penetration, and visualization is improved when the patient has fasted for at least 6hours. The sonographer should be familiar with the anatomic variations that occur, since they may be present in about 35% of patients. The most common variant is a trifurcation of the portal vein into right anterior, right pos­terior, and left portal branches.
21
Scanning often begins with the patient in the supine position but may require left lat­eral decubitus positioning to obtain the appropriate trans­abdominal, subcostal, and intercostal windows. The normal Doppler venous waveform in the portal venous circulation
11.4 Representative images demonstrating thrombus visualiza-
tion in the subclavian vein with B-mode imaging (a) and color ow (b). Color ow of one of two paired peroneal veins demon­strates a sizable peroneal DVT (c). Color ow imaging of the popliteal artery and vein (V) show absent ow in the popliteal vein.
is described as a continuous ow with a mildly pulsatile waveform (Figure11.5). Hepatic venous ow is multiphasic, with an early retrograde component during atrial contrac­tion and a double peaked forward ow, which is affected by ventricular contraction and relaxation, tricuspid opening and closure, and respiration.
21
110 Chapter 11 Duplex ultrasound scanning for acute venous disease
https://t.me/med1917
P
11.5 Doppler waveform of the portomesenteric venous circulation (splenic vein depicted), demonstrating continuous ow with a
mildly pulsatile waveform.
11.4 ACCURACY AND OUTCOMES AFTER VENOUS DUPLEX SCANNING
The accuracy of venous duplex imaging for lower extrem­ity DVT varies, depending on the presence or absence of symptoms and the anatomic location of the thrombosis (Table11.3). In a large meta-analysis, duplex imaging for patients with symptomatic DVT was associated with a signicantly higher sensitivity (89%) when compared to asymptomatic patients (47%). However, the specicities remained equivalent between the two groups (94%). With regard to location, the duplex detection of isolated calf vein thrombosis was less sensitive than for proximal veins of the lower extremities.
Accuracy of ultrasound in other anatomic locations is not as well known, typically with data from the 1990s. Based on limited information, venous duplex scanning of the IVC and iliac veins is less sensitive for detecting throm­bosis than computed tomography (CT) or magnetic res­onance imaging (MRI).
23
Data regarding the accuracy of portal venous duplex imaging also comes from single-in­stitution studies, with results shown in Table11.3. presence of underlying portal hypertension may confound the direction of ow evaluation and give a false-positive result. Careful adjustment of Doppler gain and beam posi­tioning, as well as clinical context, are essential to avoiding ambiguous results. More information is available regard­ing duplex diagnosis of upper extremity DVT, since this modality has largely replaced venography and CT angi­ography for most patients with suspected upper extrem­ity venous thrombosis. The sensitivity of upper extremity venous duplex imaging ranges from 78% to 100%, and specicity ranges from 82% to 100%.
26–28
24,25
22
19
The
TABLE 11.3 The sensitivity and specicity for venous
duplex diagnosis of DVT for symptomatic and asymptomatic patients, categorized according to anatomic venous beds
Venous bed Sensitivity Specificity
All Lower Extremity DVT*
Symptomatic patients Asymptomatic patients
Proximal Lower Extremity Veins*
Symptomatic patients Asymptomatic patients
Isolated Calf Lower Extremity DVT*
Symptomatic patients
Asymptomatic patients IVC and Iliac Veins Portal Veins Upper Extremity Veins
* From Kearon, Clive, etal. “Noninvasive Diagnosis of Deep Venous Throm­bosis.” Annals of Internal Medicine 128 (1998): 663–677.
From Laissy, J. P., “Assessment of Deep Venous Thrombosis in the Lower Limbs and Pelvis: MR Venography versus Duplex Doppler Sonography.” American Journal of Roentgenology 167 (1996): 971–975.
From Tessler, Frank N., etal. “Diagnosis of Portal Vein Thrombosis: Value of Color Doppler Imaging.” American Journal of Roentgenology 157 (1991): 293–296; Parvey HR, Eisenberg RL, Giyanani V, Krebs CA. “Duplex So­nography of the Portal Venous System: Pitfalls and Limitations.” AJR Am J Roentgenol. Apr 1989;152(4):765–70. doi:10.2214/ajr.152.4.765.
From Sajid, M., etal. “Upper Limb Deep Vein Thrombosis: ALiterature Review to Streamline the Protocol for Management.” Acta Haematologica 118 (2007): 10–18.
89% 47% 97% 62% 73% 53% 46% 89% 78%–100%
94%
94% 100% 67–92% 82%–100%
These accuracy studies, comparing duplex ultrasound with cross-sectional imaging, differ from “management studies,” in which patients who test negative for DVT and in whom anticoagulation is withheld are followed for the development of subsequent VTE. Results from manage-
11.5 Controversies in duplex scanning for acute venous disease 111
Patient presents with signs and symptoms of DVT (first episode)
sN
cluded
DV
https://t.me/med1917
ment studies conrm the efcacy of ultrasound, especially in symptomatic patients and those with more proximal extremity DVT. The previously mentioned meta-analysis demonstrated that patients who test negative on venous duplex imaging have a consistently low rate of developing conrmed VTE (2.0%) during an average of 6 months of follow-up.
22
11.5 CONTROVERSIES IN DUPLEX SCANNING FOR ACUTE VENOUS DISEASE
11.5.1 Whole leg versus proximal venous
duplex
The arguments for performing a whole leg venous duplex, versus a more limited assessment of the proximal veins (femoral and popliteal), are related to numerous factors, which include not only the clinical decision regarding ther­apeutic anticoagulation for a patient with an isolated calf DVT but also the sensitivity and specicity of calf venous duplex, the pretest probability of DVT, and D-dimer assay. In the past, patients with an isolated calf DVT did not routinely receive therapeutic anticoagulation. However,
the updated 2021 ACCP guidelines recommend therapeu­tic anticoagulation for 3 months in patients with severe symptoms or risk factors. anticoagulation for at least 3 months in patients with an unprovoked DVT (including isolated distal DVT).
29
The guidelines also recommend
30
There­fore, whole leg venous duplex imaging may signicantly affect the decision regarding antithrombotic therapy.
Another argument in favor of performing a whole leg venous duplex is the relative simplicity of the diagnostic algorithm: a technically adequate whole leg ultrasound that is negative for DVT leads to no further treatment or testing, and a test that is positive for proximal DVT leads to anticoagulation therapy. In a whole leg scan that is positive for isolated distal DVT, the clinician must decide between a follow-up duplex scan (in approximately 1–2 weeks) ver­sus therapeutic anticoagulation.
13
In contrast, the diagnos­tic algorithm for patients who receive a limited proximal venous duplex scan becomes more complicated. A scan that is positive for proximal DVT would lead to antico­agulation, whereas intersocietal guidelines suggest that a limited proximal venous duplex that is negative for DVT in patients with high clinical suspicion for DVT should be followed by one of the following: whole leg venous duplex, repeat imaging in 1 week, D-dimer assay, or conventional venography. Based on the more efcient algorithm asso­ciated with a whole leg venous duplex (as shown in Fig­ure11.6), we favor this approach.
31
11
History and physical examination
DVT risk factor assessment
Low clinical probability
D-dimer assay
Negative
T unlikely
Technically adequate duplex study?
Yes
Negative
DVT excluded Acute DVT
11.6 Diagnostic algorithm using clinical probability testing, D-dimer assay, and whole leg venous duplex scanning. (From Zierler,
Brenda K. “Ultrasonography and Diagnosis of Venous Thromboembolism.” Circulation 109 (2004): [suppl I]: I-9-I-14.)
Positive
Duplex ultrasound
Positive
Clinical probability rating
*
No
Venography or repeat
duplex imaging
Moderate or high clinical probability
Positive
*
o
D-dimer assay
Negative
DVT ex
Duplex ultrasound imaging
Technically adequate duplex?
Ye
Positive
Acute DVT
Negative
DVT excluded
Venography or repeat duplex imaging
112 Chapter 11 Duplex ultrasound scanning for acute venous disease
https://t.me/med1917
11.5.2 Unilateral versus bilateral venous duplex imaging
Bilateral venous duplex scans are performed frequently, even when patients present with unilateral signs and symp­toms. One rationale for routine bilateral scanning is the concern for silent contralateral DVT. Among patients who are diagnosed with an ipsilateral DVT, the reported rate at which a contralateral DVT is identied ranges from 3.6% to 29%. diagnosed with an asymptomatic contralateral DVT in the absence of an ipsilateral thrombosis (<1%). from a contralateral asymptomatic DVT are more likely to be chronic, are more likely to occur in hospitalized patients, and are associated with active malignancy.
mon nding in patients with unilateral symptoms, some authors have recommended that routine bilateral duplex scans should be avoided, since the vast majority of these patients would not have required any change in the man­agement of their antithrombotic therapy. recommended bilateral scanning in patients with active malignancy of contralateral thrombosis in these patient subgroups is signicantly higher than in the outpatient setting (34% versus 16%) or in patients without cancer (38.3% versus 12%). Of concern with this rationale, the absence of these clinical risk factors (inpatient setting, malignancy) still is a relatively poor negative predictor in excluding contralat­eral DVT. Scanning the contralateral asymptomatic limb, at least at the initial duplex scan, does provide the clinician with useful baseline information, since the rate of recurrent VTE can be greater than 30%.
32–35
However, a smaller number of patients are
28,31,32
Thrombi
28,30
Although unsuspected bilateral DVT is a fairly com-
28
Others have
30–32
or in hospitalized patients,31 since the rate
36
11.5.3 Scanning for residual venous obstruction (RVO) to guide antithrombotic therapy
The presence of RVO at the time of discontinuing anticoag­ulation has been shown by some authors to correlate with recurrent VTE, making it a potential tool to help optimize the duration of therapy. RVO are inconsistent, and signicant disparities remain with regard to the denition of RVO.
37
However, the data regarding
38,39
A patient-level meta-analysis demonstrated a mild association between RVO and VTE recurrence (hazard ratio 1.32), present only within the rst 3 months after diagnosis of the DVT. Without a more denitive relationship, most validated VTE recurrence prediction models exclude RVO as a factor.
40
41
That being said, a follow-up baseline venous duplex of the affected limb at the time of discontinuing anticoagulation does help clinicians interpret subsequent duplex scans in questions of recurrent VTE.
42
11.6 CONCLUSION
Venous duplex scans play a critical role in the diagnosis of acute venous thrombosis in multiple vascular beds. In gen­eral, they have a high rate of accuracy and a very low rate of complications. However, imaging should be performed for appropriate indications and may be more useful when used in combination with pretest probability scoring and D-dimer analysis. In patients with established DVT, fol­low-up duplex imaging at the time of discontinuing therapy is likely to be useful for subsequent comparisons, especially since the rate of recurrent VTE remains signicant.
Guidelines 11.0 of the American Venous Forum on duplex ultrasound scanning for acute venous disease
No. Guideline Grade of recommendation Quality of evidence
11.1 Duplex ultrasound scanning is the standard of care to diag­nose acute deep vein thrombosis (DVT) of the limbs.
11.2 Duplex examination for DVT should include three components in each vein segment studied: thrombus visualization, venous coaptability or compressibility, and detection of venous ow.
11.3 Duplex scanning has a sensitivity of >90% for the detection of symptomatic femoropopliteal thrombosis and a range of 50%–70% for calf vein thrombosis.
11.4 Duplex scanning for upper extremity DVT has a sensitivity between 78% and 100% anda specicity between 82% and 100%.
1 (strong)
1 (strong)
2 (weak)
2 (weak)
A (high)
A (high)
B (moderate)
B (moderate)
REFERENCES
Systematic review Guidelines
1. Anderson FA, Jr., Wheeler HB, Goldberg RJ, etal. Apopulation-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. May1991;151(5):933–8.
2. White RH. The epidemiology of venous thromboembolism. Circulation. Jun 17 2003;107(23 Suppl 1):I4–8. doi:
10.1161/01.cir.0000078468.11849.66
3. Ofce of the Surgeon G, National Heart LaBI. Publications and reports of the surgeon general. In: The Surgeon General’s
Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism.
Ofce of the Surgeon General (US); 2008.
4. Sumner DS, Baker DW, Strandness DE, Jr. The ultrasonic velocity detector in a clinical study of venous disease. Arch Surg. Jul 1968;97(1):75–80. doi: 10.1001/ archsurg.1968.01340010105011
5. Hull R, Hirsh J, Sackett DL, Powers P, Turpie AG, Walker I. Combined use of leg scanning and impedance plethysmogra­phy in suspected venous thrombosis. An alternative to venography. N Engl J Med.
References 113
https://t.me/med1917
Jun 30 1977;296(26):1497–500. doi:
10.1056/nejm197706302962604
6. Killewich LA, Bedford GR, Beach KW, Strandness DE, Jr. Diagnosis of deep venous thrombosis. Aprospective study comparing duplex scanning to contrast venography. Circulation. Apr 1989;79(4):810–4. doi:
10.1161/01.cir.79.4.810
7. Fowl RJ, Strothman GB, Blebea J, Rosen­thal GJ, Kempczinski RF. Inappropriate use of venous duplex scans: An analysis of indications and results. J Vasc Surg. May1996;23(5):881–5; discussion 885–6. doi: 10.1016/s0741-5214(96)70251-3
8. Büller HR, Ten Cate-Hoek AJ, Hoes AW, etal. Safely ruling out deep venous throm­bosis in primary care. Ann Intern Med. Feb 17 2009;150(4):229–35.
9. Gornik HL, Gerhard-Herman MD, Misra S, Mohler ER, 3rd, Zierler RE. ACCF/ ACR/AIUM/ASE/IAC/SCAI/SCVS/SIR/ SVM/SVS/SVU 2013 appropriate use criteria for peripheral vascular ultra­sound and physiological testing part II: Testing for venous disease and evaluation of hemodialysis access: Areport of the american college of cardiology foundation appropriate use criteria task force. J Am Coll Cardiol. Aug 13 2013;62(7):649–65. doi: 10.1016/j.jacc.2013.05.001
10. Jones RT, Kabnick LS. Perioperative duplex ultrasound following endother­mal ablation of the saphenous vein: Is it worthless? J Invasive Cardiol. Oct 2014;26(10):548–50.
11. Wells PS, Anderson DR, Rodger M, etal. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. Sep 25 2003;349(13): 1227–35. doi: 10.1056/NEJMoa023153
12. Geersing GJ, Zuithoff NP, Kearon C, etal. Exclusion of deep vein thrombosis using the Wells rule in clinically important sub­groups: Individual patient data meta-ana­lysis. Bmj. Mar 10 2014;348:g1340. doi:
10.1136/bmj.g1340
13. Bates SM, Jaeschke R, Stevens SM, etal.
Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. Feb 2012;141(2 Suppl):e351S–418S. doi: 10.1378/chest.11-2299
14. Kleinjan A, Di Nisio M, Beyer-Westendorf J, etal. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for sus­pected upper extremity deep venous throm­bosis: Aprospective management study. Ann Intern Med. Apr 1 2014;160(7):451–7. doi:
10.7326/m13-2056
15. Crossin JD, Muradali D, Wilson SR. US of liver transplants: Normal and abnormal. Radiographics. Sep-Oct 2003;23(5):1093–
114. doi: 10.1148/rg.235035031
16. Lee H, Lim CW, Yoo SH, etal. The effect of Doppler ultrasound on early vascu­lar interventions and clinical outcomes after liver transplantation. World J Surg. Dec 2014;38(12):3202–9. doi: 10.1007/ s00268-014-2721-x
17. Commission IA. IAC standards and gui-
delines for vascular testing accreditation.
2015. https://intersocietal.org/programs/ vascular-testing/standards/
18. Mansour MA. Venous duplex ultrasound of the lower extremity in the diagnosis of
deep venous thrombosis. In: AbuRahma AF, DFB, ed. Noninvasive Vascular Dia-
gnosis: APractical Guide to Therapy, Third Edition. Springer-Verlag; 2013:473–81.
19. Forauer AR, Theoharis CG, Dasika NL. Jugular vein catheter placement: Histologic features and development of catheter-related (brin) sheaths in a swine model. Radiology. Aug 2006;240(2):427–
34. doi: 10.1148/radiol.2402031129
20. Merritt CR. Ultrasonographic demons­tration of portal vein thrombosis. Radiology. Nov 1979;133(2):425–7. doi:
10.1148/133.2.425
21. Benson CB, Frates MC. Ultrasound of the hepatoportal circulation. In: Abu­Rahma AF, Bandyk DF, eds. Noninvasive
Vascular Diagnosis: APractical Guide to Therapy, Third Edition. Springer-Verlag;
2007:565–87.
22. Kearon C, Julian JA, Newman TE, Gins-
berg JS. Noninvasive diagnosis of deep venous thrombosis. McMaster diagnostic imaging practice guidelines initiative. Ann Intern Med. Apr 15 1998;128(8):663–77. doi: 10.7326/0003-4819-128-8­199804150-00011
23. Laissy JP, Cinqualbre A, Loshkajian A, etal. Assessment of deep venous thrombosis in the lower limbs and pelvis: MRvenography versus duplex Doppler sonography. AJR Am J Roentgenol. Oct 1996;167(4):971–5. doi: 10.2214/ ajr.167.4.8819396
24. Tessler FN, Gehring BJ, Gomes AS, etal. Diagnosis of portal vein thrombosis: Value of color Doppler imaging. AJR Am J Roentgenol. Aug 1991;157(2):293–6. doi: 10.2214/ajr.157.2.1853809
25. Parvey HR, Eisenberg RL, Giyanani V, Krebs CA. Duplex sonography of the portal venous system: Pitfalls and limitations. AJR Am J Roentgenol. Apr 1989;152(4):765–70. doi: 10.2214/ ajr.152.4.765
26. Sottiurai VS, Towner K, McDonnell AE, Zarins CK. Diagnosis of upper extremity deep venous thrombosis using noninvasive technique. Surgery. May1982;91(5):582–5.
27. Falk RL, Smith DF. Thrombosis of upper extremity thoracic inlet veins: Diagnosis with duplex Doppler sonography. AJR Am J Roentgenol. Oct 1987;149(4): 677–82. doi: 10.2214/ajr.149.4.677
28. Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G. Upper limb deep vein thrombosis: Aliterature review to streamline the protocol for management. Acta Haematol. 2007;118(1):10–8. doi:
10.1159/000101700
29. Stevens SM, Woller SC, Kreuziger LB,
etal. Antithrombotic therapy for VTE disease: Second update of the CHEST gui­deline and expert panel report. Chest. Dec 2021;160(6):e545–608. doi: 10.1016/j. chest.2021.07.055
30. Kearon C, Akl EA, Comerota AJ, etal.
Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. Feb 2012;141(2 Sup­pl):e419S–6S. doi: 10.1378/chest.11-2301
31. Zierler BK. Ultrasonography and diagnosis of venous thromboembo­lism. Circulation. Mar 30 2004;109(12
Suppl 1):I9–14. doi: 10.1161/01. CIR.0000122870.22669.4a
32. Strothman G, Blebea J, Fowl RJ, Rosen­thal G. Contralateral duplex scanning for deep venous thrombosis is unnecessary in patients with symptoms. J Vasc Surg. Nov 1995;22(5):543–7. doi: 10.1016/s0741­5214(95)70035-8
33. Prandoni P, Lensing AW, Piccioli A, Bagatella P, Girolami A. Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis. Lancet. 1998;9130:786.
34. Le Gal G, Robert-Ebadi H, Carrier M, Kearon C, Bounameaux H, Righini M. Is it useful to also image the asympto­matic leg in patients with suspected deep vein thrombosis? J Thromb Haemost. Apr 2015;13(4):563–6. doi: 10.1111/ jth.12851
35. Pennell RC, Mantese VA, Westfall SG. Duplex scan for deep vein thrombo­sis–Dening who needs an examination of the contralateral asymptomatic leg. J Vasc Surg. Aug 2008;48(2):413–6. doi:
10.1016/j.jvs.2008.03.046
36. Heit JA, Mohr DN, Silverstein MD, Pet­tersonTM, O’Fallon WM, Melton LJ, 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: Apopulation-based cohort study. Arch Intern Med. Mar 27 2000;160(6):761–8. doi: 10.1001/archinte.160.6.761
37. Siragusa S, Malato A, Anastasio R, etal. Residual vein thrombosis to establish duration of anticoagulation after a rst episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood. Aug 1 2008;112(3):511–5. doi: 10.1182/blood-2008-01-131656
38. Stephenson EJ, Liem TK. Duplex imaging of residual venous obstruction to guide duration of therapy for lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. Jul 2015;3(3):326–32. doi: 10.1016/j. jvsv.2014.08.003
39. Carrier M, Rodger MA, Wells PS, Righini
M, Gal LEG. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: Asystematic review and meta-analysis. J Thromb Haemost. Jun 2011;9(6):1119–25. doi: 10.1111/j.1538-
7836.2011.04254.x
40. Donadini MP, Ageno W, Antonucci E, etal. Prognostic signicance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: Apatient-level meta-analysis. Thromb Haemost. Jan 2014;111(1):172–9. doi:
10.1160/th13-04-0336
41. Kyrle PA, Eichinger S. Clinical scores to predict recurrence risk of venous thromboembolism. Thromb Haemost. Dec 2012;108(6):1061–4. doi: 10.1160/ th12-05-0353
42. Hamadah A, Alwasaidi T, LEG, G, etal. Baseline imaging after therapy for unprovoked venous thromboembolism: Arandomized controlled comparison of baseline imaging for diagnosis of suspected recurrence. J Thromb Hae- most. Dec 2011;9(12):2406–10. doi:
10.1111/j.1538-7836.2011.04533.x
11